rosiglitazone has been researched along with Pain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godai, K; Hasegawa-Moriyama, M; Kanmura, Y; Kojima, M; Kurimoto, T; Kuwaki, T; Nakama, M | 1 |
| Abdel-Aleem, OS; Badr, MZ; Donahue, RR; McNamara, KC; Morgenweck, J; Taylor, BK | 1 |
| Antoniou, T; Berger, P; Kennie, N | 1 |
3 other study(ies) available for rosiglitazone and Pain
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages.
Topics: Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Clodronic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Freund's Adjuvant; Gene Expression Regulation; Heme Oxygenase-1; Hyperalgesia; Inflammation; Lectins, C-Type; Macrophages, Peritoneal; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pain; Pain Measurement; Pain Threshold; Receptors, Cell Surface; Rosiglitazone; Thiazolidinediones; Time Factors | 2013 |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Animal; Edema; Epoxy Compounds; Gene Expression; Inflammation; Male; Pain; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Thiazolidinediones | 2010 |
Elevated creatine kinase and myalgia in a patient taking rosiglitazone.
Topics: Adult; Creatine Kinase; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Male; Muscular Diseases; Pain; Rosiglitazone; Thiazolidinediones | 2007 |